Treatments of AIDS-related Kaposi's sarcoma

Critical Reviews in Oncology/Hematology

Volumn 53, Issue 3, 2005, Pages 253-265

  Aversa, Savina Maria Lucia ^a,b   Cattelan, Anna Maria ^b   Salvagno, Luigi ^c   Crivellari, Gino ^a   Banna, Giuseppe ^a   Trevenzoli, Marco ^b   Chiarion Sileni, Vanna ^a   Monfardini, Silvio ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c GENERAL HOSPITAL   (Italy)

Author keywords

AIDS related Kaposi's sarcoma; Kaposi's sarcoma

Indexed keywords

4 DEDIMETHYLAMINOSANCYCLINE; ACICLOVIR; ALITRETINOIN; ALPHA INTERFERON; ANTHRACYCLINE; BLEOMYCIN; CHORIONIC GONADOTROPIN; DAUNORUBICIN; DIDANOSINE; DOXORUBICIN; ETOPOSIDE; FOSCARNET; FUMAGILLOL CHLOROACETYLCARBAMATE; GANCICLOVIR; IM 862; ISOTRETINOIN; PACLITAXEL; PROTEINASE INHIBITOR; RETINOIC ACID; RNA DIRECTED DNA POLYMERASE INHIBITOR; TECOGALAN; THALIDOMIDE; VINBLASTINE; VINCA ALKALOID; VINCRISTINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALOPECIA; ANGIOGENESIS; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CARDIOTOXICITY; CAUTERIZATION; CHEILITIS; CLINICAL TRIAL; CRYOSURGERY; DEPRESSION; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG ERUPTION; DRUG HALF LIFE; DRUG MEGADOSE; DRUG METABOLISM; DRUG SAFETY; DRUG TISSUE LEVEL; DRY SKIN; ENCAPSULATION; FATIGUE; FEVER; HAIR LOSS; HAND FOOT SYNDROME; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; INTRAOCULAR HEMORRHAGE; KAPOSI SARCOMA; LASER SURGERY; LIVER TOXICITY; LOW DRUG DOSE; MUCOSA INFLAMMATION; NEUROPATHY; NEUTROPENIA; NONHUMAN; OPPORTUNISTIC INFECTION; PAIN; PHOTOSENSITIVITY; REVIEW; SIDE EFFECT; SINUSITIS; SKIN IRRITATION; SOMNOLENCE; TRIACYLGLYCEROL BLOOD LEVEL; TUMOR GROWTH; VIREMIA;

EID: 13844256938     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2004.10.009     Document Type: Review

References (136)

1. A.E. Friedman-Kien, L. Laubstein, and M. Marmor Kaposi's sarcoma and pneumocystis pneumonia among homosexual man New York City and California MMWR Morb Mortal Wkly Rep 30 1981 305 308
2. R.J. Biggar, and C.S. Rabkin The epidemiology of AIDS-related neoplasms Hematol Oncol Clin North Am 10 1996 997 1010
3. US Centers for Disease Control and Prevention. HIV/AIDS surveillance report. MMWR Morb Mort Wkly Rep 1994;6:18.
4. J.J. Goedert, T.R. Cote, and P. Virgo Spectrum of AIDS-associated malignant disorders Lancet 351 1998 1833 1839
5. International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 2000;92:1823-30.
6. M.P. Carrieri, C. Pradier, and P. Piselli Reduced incidence of Kaposi's sarcoma and of systemic non-Hodgkin's lymphoma in HIV-infected individuals treated with highly active antiretroviral therapy Int J Cancer 103 2003 142 144
7. Centers for Disease Control 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41:1-19.
8. A. Mocroft, O. Kirk, and N. Clumeck The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA study Cancer 100 2004 2644 2654
9. V. Beral, T.A. Peterman, R.L. Berkelman, and H.W. Jaffe Kaposi's sarcoma among persons with AIDS: a sexual transmitted infection? Lancet 335 1990 123 128
10. D. Serraino, S. Franceschi, U. Tirelli, and S. Monfardini The epidemiology of acquired immunodeficiency syndrome and associated tumors in Europe Ann Oncol 3 1992 595 603
11. H.R. Wabinga, D.M. Parkin, F. Wabwire-Mangen, and J.W. Mugerula Cancer in Kampala, Uganda, in 1989-1991: changes in incidence in the era of AIDS Int J Cancer 54 1993 26 36
12. G. Nasti, E. Vaccher, D. Errante, and U. Tirelli Malignant tumors and AIDS Biomed Pharmacother 51 1997 243 251
13. P.S. Gill, B. Akil, and P. Colleti Pulmonary Kaposi's sarcoma. Clinical findings and results of therapy Am J Med 87 1989 57 61
14. L.D. Kaplan, P.C. Hopewell, H. Jaffe, P.C. Goodman, K. Bottles, and P.A. Volberding Kaposi's sarcoma involving the lung in patients with the acquired immunodeficiency syndrome J Acquir Immune Defic Syndr 1 1988 23 30
15. F.P. Ognibene, R.G. Steis, and A.M. Macher Kaposi's sarcoma causing pulmonary infiltrates and respiratory failure in the acquired immunodeficiency syndrome Ann Intern Med 102 1985 471 475
16. S.E. Krown, C. Metroka, and J.C. Wernz Kaposi's sarcoma in the acquired immunodeficiency syndrome: a proposal for uniform evaluation, response, and staging criteria J Clin Oncol 7 1989 1201 1207
17. S.E. Krown, M.A. Tosta, and J. Huang AIDS-related Kaposi's sarcoma: prospective validation of the ACTG staging classification J Clin Oncol 15 1997 3085 3092
18. G. Nasti, R. Talamini, and A. Antinori AIDS-related Kaposi's sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the HAART era. The Italian Cooperative Group on Aids and Tumors and the Italian Cohort of patients Naïve from antiretrovirals J Clin Oncol 21 2003 2876 2882
19. B. Ensoli, and M. Sturzl Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents Cytokine Growth Factor 9 1998 63 83
20. Y. Chang, E. Cesarman, and D. Knowles Identification and partial characterization of a new human herpsevirus associated with Kaposi's sarcoma AIDS Res Hum Retroviruses 11 1995 73 74
21. Y. Chang, E. Cesarman, and M.S. Pessin Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma Science 266 1994 1865 1869
22. M. Elkman, E.E. Kaaya, and M. Schalling Herpes virus like (KSHV) DNA in various forms of Kaposi's sarcoma and malignant lymphoma AIDS Res Hum Retroviruses 11 1995 S74 S78
23. A.E. Friedman-Kien, J.J. Li, and Y.Q. Huang RNA expression of the herpesvirus-like agent (KSHV) in various types of Kaposi's sarcoma (KS) lesions AIDS Hum Retroviruses 11 1995 S97
24. S.E. Krown Clinical overview: issues in Kaposi's sarcoma therapeutics J Natl Cancer Inst Monogr 23 1998 59 63
25. U. Tirelli, M. Spina, A. Carbone, and S. Monfardini Neoplastic complications of AIDS R.L. Souhami I. Tannock P. Hohenberger J.-C. Horiot Oxford textbook of oncology 2002 Oxford University Press 2477 2491
26. F.C. Lee, J.S. Cooper, and R.T. Mitsuyasu AIDS-related malignancies second ed. Cancer management: a multidisciplinary approach vol. 5 1998 PRR Huntington, NY 37 63
27. K.J. Stelzer, and T.W. Griffin A randomised prospective trial of radiation therapy for AIDS-associated Kaposi's sarcoma Int J Radiat Oncol Biol Phys 32 1995 276 277
28. B. Lewis, D. Abrams, and J. Ziegler Single agent and combination chemotherapy of Kaposi's sarcoma in acquired immunodeficiency syndrome Proc Am Soc Clin Oncol 2 1983 abstract 59
29. L.J. Laubenstein, R.L. Krigel, and C.M. Odajnyk Treatment of epidemic Kaposis's sarcoma with etoposide or a combination of doxorubicin, bleomycin and vinblastin J Clin Oncol 2 1984 1115 1120
30. P.A. Volberding, D. Abrams, M. Conant, K. Kaslow, K. Vranizan, and J. Ziegler Vinblastine therapy for Kaposi's sarcoma in the acquired immunodeficiency syndrome Ann Intern Med 103 1985 335 338
31. L. Kaplan, P.A. Volberding, and S.E. Krown Failure of mitoxantrone in AIDS-related Kaposi's sarcoma Lancet 2 8451 1985 386
32. D. Mintzer, F.X. Real, and L. Jovino Treatment of Kaposi's sarcoma and thrombocytopenia with vincristine in patients with acquired deficiency syndrome Ann Inter Med 103 1985 200 202
33. A. Chachoua, M. Green, L. Laubestein, J. Wernz, and F.M. Muggia Phase II study of oral idarubicin in patients with AIDS associated Kaposi's sarcoma Cancer Treat Rev 71 1987 775 776
34. P.E. Goss, F.A. Shepherd, and R. Burkes Phase II study of epirubicin in the treatment of Kaposi's sarcoma and AIDS Proc Am Soc Clin Oncol 3 1989 abstract 2
35. P.S. Gill, M. Rarick, and M. Berstein-Singer Treatment of advanced Kaposi's sarcoma using a combination of bleomycin and vincristine Am J Clin Oncol 13 1990 315 319
36. K. Lassoued, J.P. Clauvel, and C. Katlama Treatment of the acquired immune deficiency syndrome-related Kaposi's sarcoma with bleomycin as a single agent Cancer 66 1990 1869 1872
37. G. Schwartsmann, E. Sprinz, and M. Kromfeld Phase II study of teniposide in patients with AIDS-related Kaposi's sarcoma Eur J Cancer 27 1991 1637 1639
38. E. Caumes, G. Guermonprez, and C. Katlama AIDS-associated mucocutaneous Kaposi's sarcoma treated with bleomycin AIDS 6 1992 1483 1487
39. M.A. Fischl, S.E. Krown, and K. O'Boyle Weekly doxorubicin in the treatment of patients with AIDS related Kaposi's sarcoma J Acquir Immune Defic Syndr 6 1993 259 264
40. S.C. Remick, M. Reddy, and D. Herman Continuous infusion bleomycin in AIDS-related Kaposi's sarcoma J Clin Oncol 12 1994 1130 1136
41. G. Schwartsmann, E. Sprinz, and M. Kromfeld Clinical and pharmacokinetic study of oral etoposide in patients with AIDS-related Kaposi's sarcoma with no prior exposure to cytotoxic therapy J Clin Oncol 15 1997 2118 2124
42. D. Errante, M. Spina, and M. Tavio Evidence of activity of vinorelbine in patients with previously treated epidemic Kaposi's sarcoma Proc Am Soc Clin Oncol 16 1997 abstract 146
43. P.S. Gill, M.U. Rarick, and J.A. McCuchan Systemic of AIDS-related Kaposi's sarcoma. Results of a randomized trial Am J Med 90 1991 427 433
44. P.S. Gill, J. Wernz, and D.T. Scadden Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, vincristine (ABV) in AIDS-related Kaposi's sarcoma J Clin Oncol 14 1996 2353 2364
45. D.W. Northfelt, B. Debuze, and J.A. Thommes Pegylated liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of randomized phase III clinical trial J Clin Oncol 16 1998 2445 2451
46. S. Stewart, H. Jablononski, and F.D. Goebel Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma J Clin Oncol 16 1998 683 691
47. R. Masood, S.R. Husain, and A. Rahman Potentiation of cytotoxic of Kaposi's sarcoma related to immunodeficiency syndrome (AIDS) by liposome encapsulated doxorubicin AIDS Res Hum Retroviruses 8 1993 741 745
48. D.W. Northfelt, F.J. Martin, and P. Working Pharmacokinetics, tumor localization, and safety of pegylated-liposomal doxorubicin in patients with AIDS-related Kaposi's sarcoma J Clin Pharmacol 366 1996 55 63
49. G. Berry, M. Billingham, and E. Alderman The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi's sarcoma patients treated with pegylated liposomal doxorubicin Ann Oncol 9 1998 711 716
50. C.A. Presant, M. Scolaro, and P. Kennedy Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma Lancet 341 1993 1242 1243
51. P.S. Gill, B.M. Espina, and F. Muggia Phase I/II clinical and farmacokinetic evaluation of liposomal daunorubicin J Clin Oncol 13 1995 996 1003
52. M. Sturzl, C. Zeit, and B. Eisenburg Liposomal doxorubicin in the treatment of AIDS-associated Kaposi's sarcoma. Clinical, histological, and cell biological evaluation Res Virol 145 1994 261 269
53. M. Harrison, D. Tomlinson, and S. Stewart Liposomal-entrapped doxorubicin: an active agent in AIDS-related Kaposi's sarcoma J Clin Oncol 13 1995 914 920
54. R. Mytsuyasu, J. von Roenn, and S.E. Krown Comparison study of liposomal doxorubicin alone or with bleomycin and vincristine for treatment of advanced AIDS-associated Kaposi's sarcoma: AIDS Clinical Trial Group (ACTG) (Protocol 286) Proc Am Soc Clin Oncol 16 1997 abstract 55
55. E. Rosenthal, F. Sala, R.M. Chichmanian, M. Batt, and J.P. Cassato Ergotism related to concurrent administration of ergotamine tartrate and indinavir JAMA 281 1999 987
56. E. Rosenthal, I. Poizot-Martin, and T. Saint-Marc Phase IV study of liposomal daunorubicin (Daunoxome) in AIDS-related Kaposi's sarcoma Am J Clin Oncol (CGT) 25 2002 57 59
57. S.B. Horwitz, D. Cohen, S. Rao, I. Ringel, M.J. Shen, and C.P. Yang Taxol: mechanisms of action and resistance J Natl Cancer Inst Monogr 15 1993 55 62
58. N. Klauber, S. Parangi, E. Flynn, E. Hayel, and R.J. D'Amato Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol Cancer Res 57 1997 81 86
59. D. Belotti, V. Vergani, and T. Drudis The microtubule-affecting drug paclitaxel has antiangiogenic activity Clin Cancer Res 2 1996 1843 1849
60. M.W. Saville, J. Lietzau, and J.M. Pluda Treatment of HIV-associated Kaposi's sarcoma with paclitaxel Proc ASCO 12 1994 abstract 19
61. L. Welles, M.W. Saville, and J. Lietzau Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma J Clin Oncol 16 1998 1112 1121
62. P.S. Gill, A. Tulpule, and B.M. Espina Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma J Clin Oncol 17 1999 1876 1883
63. V.R. Nannan Panday, R.M. Hoetelmans, R.P. van Heeswijk, P.L. Meenhorst, M. Inghels, J.W. Mulder, and J.H. Beijnen Paclitaxel in the treatment of human immunodeficiency virus 1-associated Kaposi's sarcoma drug-drug interactions with protease inhibitors and a nonnucleoside reverse transcriptase inhibitor: a case report study Cancer Chemother Pharmacol 43 1999 516 519
64. D. Bundow, and D.M. Aboulafia Potential drug interaction with paclitaxel and highly active antiretroviral therapy in two patients with AIDS-associated Kaposi's sarcoma Am J Clin Oncol 27 2004 81 84
65. A. Tulupe, J. Groopman, and W.M. Saville Multicenter trial of low-dose placlitaxel in patients with advanced AIDS-related Kaposi's sarcoma Cancer 95 2002 147 154
66. S.R. Evans, S.E. Krown, M.A. Testa, T.P. Cooley, and J.H. Von Roenn Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi's sarcoma: an AIDS Clinical Trials Group clinical study J Clin Oncol 20 2002 3236 3241
67. S.E. Krown Interferon and other biological agents for the treatment of Kaposi's sarcoma Hematol Oncol Clin North Am 5 1991 311 322
68. H.C. Lane, J.A. Kovasc, and J. Feinberg Anti-retroviral effects of interferon-alpha in AIDS-associated Kaposi's sarcoma Lancet 2 1988 1218 1222
69. M. Fischl Antiretroviral therapy in combination with interferon for AIDS-related Kaposi's sarcoma Am J Med 90 1991 2S
70. S.E. Krown, J.W.M. Gold, and D. Niedzwiecki Interferon-alpha with zidovudine: safety, tolerance, and clinical and virological effects in patients with Kaposi's sarcoma associated with the acquired immunodeficiency syndrome (AIDS) Ann Intern Med 112 1990 812 821
71. F.A. Shephered, R. Beaulieu, and K. Gelmon Prospective randomized trial of two dose levels of interferon alpha with zidovudine for the treatment of Kaposi's sarcoma associated with human immunodeficiency virus infection: a Canadian HIV Clinical Trials Network Study J Clin Oncol 16 1998 1736 1742
72. S.E. Krown, P. Li, J.H. Von Roenn, J. Paredes, J. Huang, and M.A. Testa Efficacy of low-dose interferon with antiretroviral therapy in Kaposi's sarcoma: a randomized phase II AIDS Clinical Trials Group Study J Interferon Cytokine Res 22 2002 295 303
73. C.M. Perry, and J.A. Balfour Didanosine. An update on its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV disease Drugs 52 1996 928 962
74. S.M.L. Aversa, A.M. Cattelan, and L. Salvagno Chemo-immunotherapy of advanced AIDS-related Kaposi's sarcoma Tumor 85 1999 54 59
75. R. D'Amato, M.S. Loughnan, E. Flynn, and J. Folkman Thalidomide is an inhibitor of angiogenseis Proc Natl Acad Sci USA 91 1994 4082 4085
76. R.F. Little, J.M. Pluda, and K.M. Wyvill Activity of thalidomide in AIDS-related Kaposi's sarcoma J Clin Oncol 18 2000 2593 2602
77. B.J. Dezube, J.H. von Roenn, and J. Holden-Wiltse A phase I dose escalation and pharmacokinetics study of TNP-470 in AIDS-related Kaposi's sarcoma (ACTG-215) J Clin Oncol 16 1998 1444 1449
78. S. Nakamura, S. Sakurada, and S.Z. Salahuddin Inhibition of development of Kaposi's sarcoma related lesions by a bacterial cell wall complex Science 255 1992 1437 1440
79. J.M. Pluda, L.E. Shay, and A. Foli Administration of pentosan polysulfate to patients with human immunodeficiency virus-associated Kaposi's sarcoma J Natl Cancer Inst 85 1993 1585 1592
80. A. Tulpule, J.C. Snyder, and B.M. Espina A phase I study of tecogalan, a novel angiogenesis inhibitor in the treatment of AIDS-related Kaposi's sarcoma and solid tumor Blood 84 Suppl. 1 1994 abstract 248
81. S.G. Eckhardt, H.A. Burris, and J.R. Eckardt A phase I clinical and pharmacokinetic study of the angiogenesis inhibitor, tecogalan sodium Ann Oncol 7 1996 491 496
82. A. Tulpule, B.M. Espina, and S. Cabriales IM-862 nasal solution is an active antiangiogenic agent in the treatment of AIDS-related Kaposi's sarcoma Proc Am Soc Clin Oncol 18 1999 abstract 535
83. IM862 (investigator's brochure) 1 August 1998, sixth ed. Kirland, WA: Cytran Inc.; 1998.
84. A. Tulpule, D.T. Scadden, and B.M. Espina Results of a randomized study of IM862 nasal solution in the treatment of AIDS-related Kaposi's sarcoma J Clin Oncol 18 2000 716 723
85. P.E. Jolly, Y.L. Yang, J.O. Alvarez, and T.A. Smoot Vitamin A depletion in HIV infection and AIDS AIDS 10 1996 114
86. A. Ladoux, E.J. Cragoe, B. Geny, J.P. Abita, and C. Frelin Differentiation of human promyelocitic HL 60 cells by retinoic acid is accompanied by an increase in the intracellular pH J Biol Chem 262 1987 811 816
87. E. Dmitrovsky, and G.J. Bosl Active cancer therapy combining 13-cis-retinoic acid with interferon α J Natl Cancer Inst 84 1992 218 219
88. P. Fenaux, and L. Degos Differentiation therapy for acute promyelocitic leukemia N Engl J Med 377 1997 1076 1077
89. W.X. Guo, P.S. Gill, and T. Antakly Inhibition of AIDS-Kaposi's sarcoma cell proliferation following retinoic acid receptor activation Cancer Res 55 1995 823 829
90. J. Corbeil, E. Rapaport, and D.D. Richman Antiproliferative effect of retinoid compounds on Kaposi's sarcoma cells J Clin Invest 93 1994 1981 1986
91. L. Bonhomme, G. Fredj, and S. Averous Topical treatment of epidemic Kaposi's sarcoma with all trans retinoic acid Ann Oncol 2 1991 234 235
92. P.S. Gill, B.M. Espina, and T. Moudgil All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma. Results of a pilot phase II study Leukemia 8 1995 S26 S32
93. J. Bailey, J.M. Pluda, and A. Foli Phase I/II study of intermittent all trans retinoic acid alone and in combination with interferon-alfa 2a in patients with epidemic Kaposi's sarcoma J Clin Oncol 13 1995 1966 1974
94. J. Von Roenn, C. von Gunten, and M. Mullane All trans retinoic acid (ATRA) in the treatment of AIDS-related Kaposi's sarcoma: a phase II Illinois Cancer Center Study Proc Am Soc Clin Oncol 12 1993 abstract 51
95. P. Saiag, M. Pavlovic, and T. Clerici Treatment of early AIDS-related Kaposi's sarcoma with oral all-trans-retinoic acid: results of a sequential non-randomized phase II trial AIDS 12 1998 2169 2176
96. J.L. Zeigler, P.A. Volberding, and L.M. Itri Failure of isotretioin in Kaposi's sarcoma Lancet 2 1984 641
97. Z.P. Berneistein, A. Chanan-Khan, K. Miller, D.H. Northfelt, G. Lopez Berenstein, and P.S. Gill A multicenter phase II study of the intravenous administration of liposomal tretinoin in patients with acquired immunodeficiency syndrome-associated Kaposi's sarcoma Cancer 95 2002 2555 2561
98. A.E. Friedman-Kein, B. Dezube, and J. Lee Oral 9-cis retinoic acid in AIDS-related Kaposi's sarcoma. AIDS Malignancy Consortium Study 002 J Acquir Immune Defic Syndr Hum Retroviruses 17 1998 abstract 24
99. D. Aboulafia, D. Norris, and R.J. Grossman Interim analysis of Phase II study (Protocol L1057-280) of panretin capsules for AIDS related Kaposi's sarcoma J Acquir Immune Defic Syndr Hum Retroviruses 17 1998 abstract 25
100. M. Duvic, A.E. Friedman-Kien, and D.J. Looney Topical treatment of cutaneous lesions of acquired immnuodeficiency syndrome-related Kaposi's sarcoma using alitretinoin gel Arch Dermatol 136 2000 1461 1469
101. A. Albini, G. Fontanini, and L. Masiello Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatans and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloprotinase-2 AIDS 8 1994 1237 1244
102. O. Prakash, Z.Y. Tang, and Y.E. He Human Kaposi's sarcoma cell-mediated tumorigenesis in human immunodeficiency type 1 tat-expressing transgenic mice J Natl Cancer Inst 92 2000 721 728
103. B. Fingleton, and L.M. Matrisian Matrix metalloproteinases as target for therapy in Kaposi's sarcoma Curr Opin Oncol 13 2001 368 373
104. M. Cianfrocca, T.P. Cooley, and J.Y. Lee Matrix metalloprotreinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study J Clin Oncol 20 2002 153 159
105. A.S. Bourinbaier, and S. Lee-Huang Inibitory effect of human corionic gonadotropin (hCG) on HIV-1 trasmission from lymphocytes to trophoblast FEBS 309 1992 82 84
106. P.S. Gill, Y. Lunardi-Iskandar, and S. Louie Human chorionic gonodotropin has antitumor activity in AIDS-related Kaposi's sarcoma N Engl J Med 335 1996 261 269
107. P.S. Gill, T. McLaughlin, and B.M. Espina Phase I study of a preparation of human chorionic gonadotropin given subcutaneously to patients with AIDS-related Kaposi's sarcoma J Natl Cancer Inst 89 1997 1797 1802
108. M. Tavio, G. Nasti, and C. Simonelli Human chorionic gonadotropin in the treatment of HIV-related Kaposi's sarcoma Eur J Cancer 34 1998 1634 1637
109. U. Pfeffer, D. Bisacchi, and M. Morini Human chorionic gonadotropin inhibits Kaposi's sarcoma associated angiogenesis, matrix metalloproteinase activity, and tumor growth Endocrinology 143 2002 3114 3121
110. M. Murphy, D. Armstrong, K.A. Sepkowitz, R.N. Ankami, and P.L. Myskowiski Regression of AIDS-related Kaposi's sarcoma following treatment with an HIV-1 protease inhibitor AIDS 11 1997 261 262
111. M.A. Conant, K.M. Opp, D. Poretz, and R.G. Mills Reduction of Kaposi's sarcoma lesions following treatment of AIDS with ritonavir AIDS 11 1997 1300 1301
112. L. Blum, C. Pellet, and F. Agbalika Complete remission of AIDS-related Kaposi's sarcoma associated with undetectable human herpesvirus-8 sequences during anti-HIV protease therapy AIDS 11 1997 1653 1655
113. A.E. Bredick, C. Carmichael, P.L. Rady, S.K. Tyring, and E. Badiavas Resolution of Kaposi's sarcoma associated with undetectable viral level of human herpes-virus 8 DNA in a patient with AIDS after protease inhibitors therapy J Am Acad Dermatol 37 1997 648 649
114. D.M. Aboulafia Regression of acquired immunodeficiency syndrome related pulmonary Kaposi's sarcoma after highly active antiretroviral therapy Mayo Clin Proc 73 1998 439 443
115. M. Bower, P. Fox, K. Fife, J. Gill, M. Nelson, and B.G. Gazzard Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma AIDS 13 1999 2105 2111
116. C. Lebbè, L. Blum, and C. Pellet Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma AIDS 12 1998 F45 F49
117. N. Dupin, V. Rubin De Cervens, and I. Gorin The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma Br J Dermatol 140 1999 875 881
118. A.M. Cattelan, M.L. Calabrò, and SM.L. Aversa Regression of AIDS-related Kaposi's sarcoma following antiretroviral therapy with protease inhibitors: biological correlated of clinical outcome Eur J Cancer 35 1999 1809 1815
119. A.M. Cattelan, M.L. Calabrò, and P. Gasperini Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biological correlates of clinical outcome J Natl Cancer Inst Monogr 28 2001 44 49
120. S. Monfardini, A.M. Cattelan, and A. De Rossi Highly effective antiretroviral therapy (HAART) and clinical outcome of AIDS related Kaposi's sarcoma: a prospective study Proc Am Soc Clin Oncol 82 2003 Abstract 3295
121. C. Dupont, E. Vasseur, and A. Beauchet Long term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients AIDS 14 2000 987 993
122. G. Mudarca, A. Campelli, M. Setti, F. Indivieri, and F. Puppo Complete remission of AIDS/Kaposi's sarcoma after treatment with a combination of two nucleoside transcriptase inhibitors and one non-nucleoside reverse transcriptase inhibitor AIDS 16 2002 304 305
123. I. Penn Kaposi's sarcoma in transplant recipients Transplantation 64 1997 669 673
124. B. Ensoli, R. Gendelman, and P. Markham Synergy between basic fibroblast growth factor and HIV-1 tat protein in induction of Kaposi's sarcoma development Nature 371 1994 674 680
125. H.C. Chang, R.C. Gallo, and B. Ensoli Regulation of cellular gene expression and function by the human immunodeficiency virus type I tat protein J Biomed Sci 95 1995 1723 1734
126. J. Stebbing, S. Portsmouth, and M. Nelson The efficacy of ritonavir in the prevention of AIDS-related Kaposi's sarcoma Int J Cancer 108 2004 631 633
127. S.E. Krown Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma: implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi's sarcoma J Clin Oncol 22 2004 399 402
128. D.J. Looney, W. Wikthe, and E. Feigal Relationship of HHV-8 peripheral blood mononuclear cell burden to immunodeficiency, opportunistic infections, response to therapy and stage of Kaposi's sarcoma. First National AIDS Malignancy Conference, Bethesda, MD J Acquir Immune Defic Syndr 14 1997 abstract 35
129. B. Quinlevan, D. Ye, and R. Wehkie Frequency of HHV-8 detection in peripheral blood cells in patients with Kapsosi's sarcoma. First National AIDS Malignancy Conference, Bethesda, MD J Acquir Immune Defic Syndr 14 1997 Abstract 32
130. M.J. Gelsby, D.R. Hoover, and S. Weng Use of anti-herpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study AIDS 10 1996 1101 1105
131. A. Mocroft, M. Youle, B. Gazzard, J. Morcinek, R. Halai, and A.N. Phillis Anti-herpesvirus treatment and the risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group J Clin Invest 99 1997 2082 2086
132. L. Morfeldt, and J. Torssander Long-term remission of Kaposi's sarcoma following foscarnet treatment in HIV-infected patients Scan J Infect Dis 26 1994 749 752
133. J.L. Jones, D.L. Hanson, S.Y. Chu, J.W. Ward, and H.W. Jaffe AIDS-associated Kaposi's sarcoma Science 267 1995 1078 1079
134. D.H. Kedes, and D. Ganem Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs J Clin Invest 99 1997 2082 2086
135. P. Brown, and R. Giavazzi Matrix metalloproteinase inhibition: a review of anti-tumor activity Ann Oncol 6 1995 967 974
136. B. Ensoli, P. Markham, and V. Kao Block of AIDS-Kaposi's sarcoma cell growth, angiogenesis and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor: a novel strategy for the therapy of KS J Clin Invest 94 1994 1736 1746